Showing results (211-220 of 258) with videos related to
Sort By:
Pageof 26
Journal of Drugs in Dermatology : JDD|June 4, 2025
Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Robert Bissonnette, et al.European Journal of Dermatology : EJD|October 27, 2022
Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trialsAndreas Wollenberg, Peter Lio, Elise Kleyn, et al.Journal of the American Academy of Dermatology|May 18, 2025
Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitisRobert Bissonnette, Linda Stein Gold, Leon Kircik, et al.The New England Journal of Medicine|November 5, 2025
Oral Icotrokinra for Plaque Psoriasis in Adults and AdolescentsRobert Bissonnette, Jennifer Soung, Adelaide A Hebert, et al.Dermatology and Therapy|July 13, 2024
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 WeeksGil Yosipovitch, Peter Lio, Franz J Legat, et al.Allergy and Asthma Proceedings|September 3, 2021
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbiditiesJonathan M Spergel, Michael S Blaiss, Peter Lio, et al.Journal of Drugs in Dermatology : JDD|August 9, 2023
Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental HealthEvan A Rieder, Anneke Andriessen, Vanessa Cutler, et al.Journal of the American Academy of Dermatology|May 22, 2024
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trialsJonathan I Silverberg, Lawrence F Eichenfield, Adelaide A Hebert, et al.Journal of Drugs in Dermatology : JDD|December 21, 2020
An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry SkinJalal Maghfour, Hope R Rietcheck, Chandler W Rundle, et al.Seminars in Cutaneous Medicine and Surgery|September 13, 2017
Atopic dermatitis: addressing allergy, infection, itch and complementary therapiesJusleen Ahluwalia, Dawn Marie Davis, Sharon Jacob, et al.Pageof 26